articleJournal of Clinical OncologyDec 13, 2010BRONZE OA

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

Istituti di Ricovero e Cura a Carattere Scientifico · Palmetto Hematology Oncology

PubMed
Indexed incrossrefpubmed

Abstract

PURPOSE: The Dynamic International Prognostic Scoring System (DIPSS) for primary myelofibrosis (PMF) uses five risk factors to predict survival: age older than 65 years, hemoglobin lower than 10 g/dL, leukocytes higher than 25 × 10(9)/L, circulating blasts ≥ 1%, and constitutional symptoms. The main objective of this study was to refine DIPSS by incorporating prognostic information from karyotype, platelet count, and transfusion status. PATIENTS AND METHODS: Mayo Clinic databases for PMF were used to identify patients with available bone marrow histologic and cytogenetic information. RESULTS: Seven hundred ninety-three consecutive patients were selected and divided into two groups based on whether or not their…

No related works found for this paper.